Pituitary Cancer Market, By Cancer Type, By Hormone Type, By Treatment Type, By Age Group, By End User, By Geography

Description

The global pituitary cancer market size was estimated to be US$ 380.7 million in 2023 and is projected to reach US$ 723.2 million by 2030, growing at a CAGR of 9.6% during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 380.7 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	9.60%	2030 Value Projection:	US$ 723.3 Mn

Figure 1. Global Pituitary Cancer Market Share (%), By Region, 2023

The cause of pituitary cancer is not well understood. But genetics and hormonal imbalances may play a role. Most pituitary tumors are adenomas, or noncancerous. They are not as common as pituitary gland cysts, which are benign (noncancerous).

Symptoms of pituitary cancer often include headaches, vision changes, loss of weight or an inability to gain weight, and trouble with memory and concentration. Some types of pituitary tumors release too many hormones, which can lead to a disease called Cushing's syndrome. In some cases, this disease causes the body to produce too much prolactin, which can cause thinning of the skin in the chest and arms, and weak bones in the legs and feet. Other forms of this condition can cause the breasts to make milk, even when the person is not pregnant. The condition can also cause a wide range of changes in blood pressure, including a flushed face and high blood pressure in the arms or legs.

Market Dynamics:

Rising incidences of pituitary tumors, increasing investments in research and development activities, and technological advancements in treatment methods are expected to drive growth of the global pituitary cancer market during the forecast period. In addition, increased awareness among the populace has led to a higher demand for noninvasive treatments. The market is also driven by a rise in the number of hospitals and clinics that offer specialized services for pituitary tumors.

However, the high cost of cancer treatments is a major factor expected to impede the growth of the global pituitary cancer market over the forecast period.

Key features of the study:

This report provides in-depth analysis of the global pituitary cancer market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global pituitary cancer market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Novartis International AG, Pfizer Inc., Ipsen Biopharmaceuticals, Inc., Endocyte, RECORDATI GROUP, Camurus AB, Endeavor Biomedicines, Inc., and Debiopharm International SA
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global pituitary cancer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pituitary cancer market

Global Pituitary Cancer Market Detailed Segmentation:

By Cancer Type:
- Pituitary Adenoma (Benign Tumor)
- Pituitary Carcinoma (Malignant Tumor)
By Hormone Type:
- Prolactinoma
- Growth Hormone-Secreting Tumor (Acromegaly)
- Adrenocorticotropic Hormone-Secreting Tumor (Cushing's Disease)
- Thyroid-Stimulating Hormone-Secreting Tumor (TSHoma)
- Gonadotropin-Secreting Tumor
By Treatment Type:
- Surgery
- Radiation Therapy
- Medications (e.g., dopamine agonists, somatostatin analogs, hormone replacement therapy)
- Targeted Therapy
- Chemotherapy
By Age Group:
- Pediatric
- Adult
By End User:
- Hospitals
- Specialty Clinics
- Cancer Treatment Centers
- Research Institutes
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Company Profile:
- Novartis International AG
- Pfizer Inc.
- Ipsen Biopharmaceuticals, Inc.
- Endocyte
- RECORDATI GROUP
- Camurus AB
- Endeavor Biomedicines, Inc.
- Debiopharm International SA

Product Code: CMI5851

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Pituitary Cancer, By Cancer Type
- Market Pituitary Cancer, By Hormone Type
- Market Pituitary Cancer, By Treatment Type
- Market Pituitary Cancer, By Age Group
- Market Pituitary Cancer, By End User
- Market Pituitary Cancer, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing Incidence and Prevalence
Advancements in Medical Imaging and Diagnostics
Increased Research and Development
Growing Demand for Personalized Medicine
- Restraints
Limited Awareness and Delayed Diagnosis
Lack of Standardized Treatment Guidelines
Limited Treatment Options for Aggressive Pituitary Cancers
Challenges in Drug Development
- Opportunities
Development of Targeted Therapies
Combination Therapies
Advancements in Surgical Techniques
Development of Novel Imaging Modalities
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Pituitary Cancer Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Pituitary Cancer Market , By Cancer Type, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Pituitary Adenoma (Benign Tumor)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Pituitary Carcinoma (Malignant Tumor)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

6. Pituitary Cancer Market , By Hormone Type, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Prolactinoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Growth Hormone-Secreting Tumor (Acromegaly)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Adrenocorticotropic Hormone-Secreting Tumor (Cushing's Disease)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Thyroid-Stimulating Hormone-Secreting Tumor (TSHoma)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Gonadotropin-Secreting Tumor
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)

7. Pituitary Cancer Market , By Treatment Type, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018- 2030
- Segment Trends
Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Radiation Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Medications(e.g., dopamine agonists, somatostatin analogs, hormone replacement therapy)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Targeted Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Chemotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)

8. Pituitary Cancer Market , By Age Group, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)

9. Pituitary Cancer Market , By End User, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Cancer Treatment Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)

10. Pituitary Cancer Market , By Region, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2018-2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
GCC
Israel
North Africa
Central Africa
Rest of Middle East & Africa

11. Competitive Landscape

Novartis International AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Ipsen Biopharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Endocyte
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
RECORDATI GROUP
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Camurus AB
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Endeavor Biomedicines, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Debiopharm International SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

12. Section

Research Methodology
About us